(Q36935749)

English

At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy

scientific article published on 26 April 2013

Statements

At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit